カテゴリー： GlobalInfoResearch, 世界

精神医学的薬物療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Psychiatric Medication Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102929）・商品コード：GIR9102929
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、精神医学的薬物療法の世界市場について調べ、まとめました。種類別セグメントは、抗うつ剤、抗精神病薬、抗不安薬および催眠薬、気分安定剤、刺激薬等、用途別セグメントは、病院、診療所、その他等に区分しました。精神医学的薬物療法の世界市場概観、企業動向、企業別精神医学的薬物療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・精神医学的薬物療法の市場概観
・精神医学的薬物療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・精神医学的薬物療法の企業別販売動向、市場シェア、市場集中度、競争動向
・精神医学的薬物療法の世界市場規模
・精神医学的薬物療法の北米市場分析（アメリカ、カナダ、メキシコ等）
・精神医学的薬物療法のアメリカ市場規模推移
・精神医学的薬物療法のカナダ市場規模推移
・精神医学的薬物療法のメキシコ市場規模推移
・精神医学的薬物療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・精神医学的薬物療法のドイツ市場規模推移
・精神医学的薬物療法のイギリス市場規模推移
・精神医学的薬物療法のロシア市場規模推移
・精神医学的薬物療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・精神医学的薬物療法の日本市場規模推移
・精神医学的薬物療法の中国市場規模推移
・精神医学的薬物療法の韓国市場規模推移
・精神医学的薬物療法のインド市場規模推移
・精神医学的薬物療法の東南アジア市場規模推移
・精神医学的薬物療法の南米市場分析（ブラジル、アルゼンチン等）
・精神医学的薬物療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・精神医学的薬物療法の種類別分析/販売量、売上、市場シェア（抗うつ剤、抗精神病薬、抗不安薬および催眠薬、気分安定剤、刺激薬）
・精神医学的薬物療法の用途別分析/市場規模（病院、診療所、その他）
・精神医学的薬物療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・精神医学的薬物療法の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

A psychiatric medication is a licensed psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.

Scope of the Report:
The global Psychiatric Medication Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psychiatric Medication Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Psychiatric Medication Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Psychiatric Medication Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antidepressants
Antipsychotics
Anxiolytics and Hypnotics
Mood Stabilizers
Stimulants

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

1 Psychiatric Medication Therapies Market Overview
1.1 Product Overview and Scope of Psychiatric Medication Therapies
1.2 Classification of Psychiatric Medication Therapies by Types
1.2.1 Global Psychiatric Medication Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Psychiatric Medication Therapies Revenue Market Share by Types in 2018
1.2.3 Antidepressants
1.2.4 Antipsychotics
1.2.5 Anxiolytics and Hypnotics
1.2.6 Mood Stabilizers
1.2.7 Stimulants
1.3 Global Psychiatric Medication Therapies Market by Application
1.3.1 Global Psychiatric Medication Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Psychiatric Medication Therapies Market by Regions
1.4.1 Global Psychiatric Medication Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Psychiatric Medication Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Psychiatric Medication Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psychiatric Medication Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Psychiatric Medication Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psychiatric Medication Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Psychiatric Medication Therapies (2014-2024)
2 Manufacturers Profiles
2.1 Johnson and Johnson
2.1.1 Business Overview
2.1.2 Psychiatric Medication Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson and Johnson Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Psychiatric Medication Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Psychiatric Medication Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Psychiatric Medication Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Psychiatric Medication Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.6 Allergan
2.6.1 Business Overview
2.6.2 Psychiatric Medication Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Allergan Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Psychiatric Medication Therapies Market Competition, by Players
3.1 Global Psychiatric Medication Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Psychiatric Medication Therapies Players Market Share
3.2.2 Top 10 Psychiatric Medication Therapies Players Market Share
3.3 Market Competition Trend
4 Global Psychiatric Medication Therapies Market Size by Regions
4.1 Global Psychiatric Medication Therapies Revenue and Market Share by Regions
4.2 North America Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
5 North America Psychiatric Medication Therapies Revenue by Countries
5.1 North America Psychiatric Medication Therapies Revenue by Countries (2014-2019)
5.2 USA Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
6 Europe Psychiatric Medication Therapies Revenue by Countries
6.1 Europe Psychiatric Medication Therapies Revenue by Countries (2014-2019)
6.2 Germany Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
6.4 France Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Psychiatric Medication Therapies Revenue by Countries
7.1 Asia-Pacific Psychiatric Medication Therapies Revenue by Countries (2014-2019)
7.2 China Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
7.5 India Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
8 South America Psychiatric Medication Therapies Revenue by Countries
8.1 South America Psychiatric Medication Therapies Revenue by Countries (2014-2019)
8.2 Brazil Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Psychiatric Medication Therapies by Countries
9.1 Middle East and Africa Psychiatric Medication Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
10 Global Psychiatric Medication Therapies Market Segment by Type
10.1 Global Psychiatric Medication Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Psychiatric Medication Therapies Market Forecast by Type (2019-2024)
10.3 Antidepressants Revenue Growth Rate (2014-2024)
10.4 Antipsychotics Revenue Growth Rate (2014-2024)
10.5 Anxiolytics and Hypnotics Revenue Growth Rate (2014-2024)
10.6 Mood Stabilizers Revenue Growth Rate (2014-2024)
10.7 Stimulants Revenue Growth Rate (2014-2024)
11 Global Psychiatric Medication Therapies Market Segment by Application
11.1 Global Psychiatric Medication Therapies Revenue Market Share by Application (2014-2019)
11.2 Psychiatric Medication Therapies Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Psychiatric Medication Therapies Market Size Forecast (2019-2024)
12.1 Global Psychiatric Medication Therapies Market Size Forecast (2019-2024)
12.2 Global Psychiatric Medication Therapies Market Forecast by Regions (2019-2024)
12.3 North America Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
12.6 South America Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Psychiatric Medication Therapies Picture
Table Product Specifications of Psychiatric Medication Therapies
Table Global Psychiatric Medication Therapies and Revenue (Million USD) Market Split by Product Type
Figure Global Psychiatric Medication Therapies Revenue Market Share by Types in 2018
Figure Antidepressants Picture
Figure Antipsychotics Picture
Figure Anxiolytics and Hypnotics Picture
Figure Mood Stabilizers Picture
Figure Stimulants Picture
Table Global Psychiatric Medication Therapies Revenue (Million USD) by Application (2014-2024)
Figure Psychiatric Medication Therapies Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Psychiatric Medication Therapies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Psychiatric Medication Therapies Type and Applications
Table Johnson and Johnson Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Psychiatric Medication Therapies Type and Applications
Table Eli Lilly Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Psychiatric Medication Therapies Type and Applications
Table Bristol-Myers Squibb Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Psychiatric Medication Therapies Type and Applications
Table AstraZeneca Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Psychiatric Medication Therapies Type and Applications
Table Novartis Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Psychiatric Medication Therapies Type and Applications
Table Allergan Psychiatric Medication Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Psychiatric Medication Therapies Revenue (Million USD) by Players (2014-2019)
Table Global Psychiatric Medication Therapies Revenue Share by Players (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Share by Players in 2017
Figure Global Psychiatric Medication Therapies Revenue Share by Players in 2018
Figure Global Top 5 Players Psychiatric Medication Therapies Revenue Market Share in 2018
Figure Global Top 10 Players Psychiatric Medication Therapies Revenue Market Share in 2018
Figure Global Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Psychiatric Medication Therapies Revenue (Million USD) by Regions (2014-2019)
Table Global Psychiatric Medication Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Market Share by Regions in 2018
Figure North America Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Europe Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure South America Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Table North America Psychiatric Medication Therapies Revenue by Countries (2014-2019)
Table North America Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Psychiatric Medication Therapies Revenue Market Share by Countries in 2018
Figure USA Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Canada Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Mexico Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Table Europe Psychiatric Medication Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure Europe Psychiatric Medication Therapies Revenue Market Share by Countries in 2018
Figure Germany Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure UK Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure France Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Russia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Italy Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Psychiatric Medication Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Psychiatric Medication Therapies Revenue Market Share by Countries in 2018
Figure China Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Japan Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Korea Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure India Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Table South America Psychiatric Medication Therapies Revenue by Countries (2014-2019)
Table South America Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Psychiatric Medication Therapies Revenue Market Share by Countries in 2018
Figure Brazil Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Argentina Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Colombia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Psychiatric Medication Therapies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Psychiatric Medication Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Psychiatric Medication Therapies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure UAE Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Egypt Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure Nigeria Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Figure South Africa Psychiatric Medication Therapies Revenue and Growth Rate (2014-2019)
Table Global Psychiatric Medication Therapies Revenue (Million USD) by Type (2014-2019)
Table Global Psychiatric Medication Therapies Revenue Share by Type (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Share by Type (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Share by Type in 2019
Table Global Psychiatric Medication Therapies Revenue Forecast by Type (2019-2024)
Figure Global Psychiatric Medication Therapies Market Share Forecast by Type (2019-2024)
Figure Global Antidepressants Revenue Growth Rate (2014-2019)
Figure Global Antipsychotics Revenue Growth Rate (2014-2019)
Figure Global Anxiolytics and Hypnotics Revenue Growth Rate (2014-2019)
Figure Global Mood Stabilizers Revenue Growth Rate (2014-2019)
Figure Global Stimulants Revenue Growth Rate (2014-2019)
Table Global Psychiatric Medication Therapies Revenue by Application (2014-2019)
Table Global Psychiatric Medication Therapies Revenue Share by Application (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Share by Application (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue Share by Application in 2019
Table Global Psychiatric Medication Therapies Revenue Forecast by Application (2019-2024)
Figure Global Psychiatric Medication Therapies Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Psychiatric Medication Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Psychiatric Medication Therapies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Psychiatric Medication Therapies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
Figure Europe Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
Figure South America Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Psychiatric Medication Therapies Revenue Market Forecast (2019-2024)


【掲載企業】

Johnson and Johnson、Eli Lilly、Bristol-Myers Squibb、AstraZeneca、Novartis、Allergan、

★調査レポート[精神医学的薬物療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102929)販売に関する免責事項を必ずご確認ください。
★調査レポート[精神医学的薬物療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 緑内障レーザー治療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101568 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、緑内障レーザー治療法の世界市場について調べ、まとめました。種類別セグメントは、慢性開放隅角緑内障、急性閉鎖隅角緑内障、二次緑内障、正常眼圧緑内障等、用途別セグメントは、病院、診療所、その他等に区分しました。緑内障レーザー治療法の世界市場概観、企業動向、企業別緑内障レーザー治療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・緑内障レーザー治療法の市場概観 ・緑内障レーザー治療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・緑内障レーザー治療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・緑内障レーザー治療法の世界市場規模 ・緑内障レーザー治療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・緑内障レーザー治療法のアメリカ市場規模推移 ・緑内障レーザー治療法のカナダ市場規模推移 ・緑内障レーザー治療法のメキシコ市場規模推移 ・緑内障レーザー治療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...SLT (glaucoma laser therapies) provides the benefits of argon laser trabeculoplasty without the coagulative damage that leads to scarring. Scope of the Report: The global Glaucoma Laser Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes...
  • 緑内障手術療法の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101569 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、緑内障手術療法の世界市場について調べ、まとめました。種類別セグメントは、レーザー治療、切開手術等、用途別セグメントは、病院、診療所、外科センター、その他等に区分しました。緑内障手術療法の世界市場概観、企業動向、企業別緑内障手術療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・緑内障手術療法の市場概観 ・緑内障手術療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・緑内障手術療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・緑内障手術療法の世界市場規模 ・緑内障手術療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・緑内障手術療法のアメリカ市場規模推移 ・緑内障手術療法のカナダ市場規模推移 ・緑内障手術療法のメキシコ市場規模推移 ・緑内障手術療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Surgery involves either laser treatment or making a cut in the eye to reduce the intraocular pressure. The type of surgery your doctor recommends will depend on the type and severity of your glaucoma and the general health of your eye. Scope of the Report: The global Glaucoma Surgery Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India...
  • 睡眠障害治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101587 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、睡眠障害治療の世界市場について調べ、まとめました。種類別セグメントは、不眠症、過度の睡眠、睡眠障害等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。睡眠障害治療の世界市場概観、企業動向、企業別睡眠障害治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・睡眠障害治療の市場概観 ・睡眠障害治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・睡眠障害治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・睡眠障害治療の世界市場規模 ・睡眠障害治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・睡眠障害治療のアメリカ市場規模推移 ・睡眠障害治療のカナダ市場規模推移 ・睡眠障害治療のメキシコ市場規模推移 ・睡眠障害治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime. Scope of the Report: The global Sleep Disorder Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be...

    • ◆H&Iグローバルリサーチのお客様（例）◆